Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size

Endocrine Journal

Volumn 59, Issue 6, 2012, Pages 457-464

  Ito, Yasuhiro ^a   Fukushima, Mitsuhiro ^a   Kihara, Minoru ^a   Takamura, Yuuki ^a   Kobayashi, Kaoru ^a   Miya, Akihiro ^a   Miyauchi, Akira ^a  

^a KUMA HOSPITAL   (Japan)

Author keywords

Extrathyroid extension; Lymph node metastasis; Papillary thyroid carcinoma; Prognosis; Tumor size

Indexed keywords

ADULT; ARTICLE; CANCER GRADING; CANCER LOCALIZATION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SPECIFIC SURVIVAL; CANCER SURVIVAL; CONTROLLED STUDY; DISTANT METASTASIS FREE SURVIVAL; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; RECURRENCE FREE SURVIVAL; THYROID CARCINOMA;

ADULT; CARCINOMA; CARCINOMA, PAPILLARY; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; THYROID NEOPLASMS; TUMOR BURDEN;

EID: 84863705392     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ12-0013     Document Type: Article

References (20)

1. th ed. New York: Wiley-Blackwell.
2. Cady B, Rosai R (1988) An expanded view of risk group definition in differentiated thyroid carcinoma. Surgery 104: 947-953.
3. Hay ID, Bergstrahl EJ, Goellner JR, Ebersold JR, Grant CS (1993) Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 114: 1050-1058.
4. Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A (2004) A novel classification system for patients with PTC: addition of the new variable of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135: 139-148.
5. Ito Y, Ichihara K, Masuoka H, Fukushima M, Inoue H, Kihara M, Tomoda C, Higashiyama T, Takamura Y, Kobayashi K, Miya A, Miyauchi A (2010) Establishment of an intraoperative staging system (iStage) by improving UICC TNM classification system for papillary thyroid carcinoma. World J Surg 34: 2570-2580.
6. Ito Y, Uruno T, Nakano K, Takamura Y, Miiya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A (2003) An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13: 381-387.
7. Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara H, Higashiyama T, Tomoda C, Takamura Y, Kobayashi K, Miya A (2010) An observation trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg 34: 28-35.
8. Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y (2010) Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 34: 1222-1231.
9. Ito Y, Masuoka H, Fukushima M, Inoue H, Kihara M, Tomoda C, Higashiyama T, Takamura Y, Kobayashi K, Miya A, MIyauchi A (2010) Excellent prognosis of patients with solitary T1N0M0 papillary thyroid carcinoma who underwent thyroidectomy and elective lymph node dissection without radioiodine therapy. World J Surg 34: 1285-1290.
10. Ito Y, Kudo T, Kihara M, Takamura Y, Kobayashi K, Miya A, Miyauchi A (2012) Prognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumors. Endocr J 59: 119-125.
11. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006) Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30: 780-786.
12. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2006) Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45. Surg Today 36: 12-18.
13. Ito Y, Miyauchi A, Jikuzono T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Ichihara K, Kuma K (2007) Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping. World J Surg 31: 838-848.
14. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A (2005) Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29: 917-920.
15. Fukushima M, Ito Y, Hirokawa M, Miya A, Shimizu K, Miyauchi A (2010) Prognostic impact of extrathyroid extension and clinical lymph node metastasis in papillary thyroid carcinoma depend on carcinoma size. World J Surg 34: 3007-3014.
16. Ito Y, Fukushima M, Tomoda C, Inoue H, Kihara M, Higashiyama T, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A (2009) Prognosis of patients with papillary carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J 56: 759-766.
17. Ito Y, Kudo T, Takamura Y, Kobayashi K, Miya A, Miyauchi A (2011) Prognostic significance of carcinoma extension from primary lesions and metastatic nodes in papillary thyroid carcinoma: appropriateness of three subdivisions of extension. Endocr J 58: 961-967.
18. Ito Y, Miyauchi A (2009) Prognostic factor and therapeutic strategies for differentiated carcinomas of the thyroid. Endocr J 56: 177-192.
19. Ito Y, Kudo T, Kobayashi K, Miya A, Ichihara K, Miyauchi A (2012) Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung and bone: analysis of 5,768 patients with average 10-year follow-up. World J Surg 36:1274-1278.
20. Takami H, Ito Y, Okamoto T, Yoshida A (2011) Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons. World J Surg 35: 111-121.